No connection

Search Results

PRFX vs SPRC

PRFX
PRF Technologies Ltd.
BEARISH
Price
$2.73
Market Cap
$2.3M
Sector
Healthcare
AI Confidence
95%
SPRC
SciSparc Ltd.
BEARISH
Price
$4.42
Market Cap
$2.5M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
PRFX
--
SPRC
0.0
Forward P/E
PRFX
-0.23
SPRC
--
P/B Ratio
PRFX
0.27
SPRC
0.03
P/S Ratio
PRFX
135.62
SPRC
1.91
EV/EBITDA
PRFX
0.25
SPRC
--

Profitability

Gross Margin
PRFX
0.0%
SPRC
38.74%
Operating Margin
PRFX
-16200.0%
SPRC
-569.52%
Profit Margin
PRFX
0.0%
SPRC
0.0%
ROE
PRFX
-90.37%
SPRC
-1281.49%
ROA
PRFX
-38.75%
SPRC
--

Growth

Revenue Growth
PRFX
--
SPRC
--
Earnings Growth
PRFX
--
SPRC
--

Financial Health

Debt/Equity
PRFX
0.0
SPRC
--
Current Ratio
PRFX
1.78
SPRC
--
Quick Ratio
PRFX
1.75
SPRC
--

Dividends

Dividend Yield
PRFX
--
SPRC
--
Payout Ratio
PRFX
0.0%
SPRC
0.0%

AI Verdict

PRFX BEARISH

PRFX exhibits severe financial distress, characterized by a Piotroski F-Score of 4/9, which barely places it in the 'stable' category despite catastrophic operating margins of -16,200%. The absence of an Altman Z-Score and Graham Number reflects a lack of positive earnings and stable valuation foundations. With a Price-to-Sales ratio of 135.62 and a 5-year price collapse of 99.7%, the company appears to be a speculative shell with virtually no meaningful revenue generation. While the current ratio of 1.78 provides a temporary liquidity cushion, the fundamental business model is currently non-viable.

Strengths
Zero debt-to-equity ratio
Current ratio of 1.78 indicates short-term liquidity
Recent Q/Q EPS growth showing improvement from deep negatives
Risks
Extreme operating margin of -16,200% indicating massive inefficiency
Absurdly high Price-to-Sales ratio (135.62) suggesting negligible revenue
Total collapse of long-term shareholder value (-99.7% over 5 years)
SPRC BEARISH

SPRC exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a catastrophic ROE of -1281.49%. The company has experienced a massive valuation collapse, falling from a 52-week high of $94.50 to $4.42, representing a 91.7% decline over the last year. With an operating margin of -569.52% and a total lack of analyst coverage, the business model appears unsustainable. The recent 1-week price spike of 40.3% is likely a speculative 'dead cat bounce' rather than a fundamental recovery.

Strengths
Positive gross margin of 38.74%
Extremely low Price-to-Book ratio (0.03)
Recent short-term price volatility providing speculative entry points
Risks
Extreme bankruptcy risk indicated by negative ROE and weak F-Score
Severe operational inefficiency with -569.52% operating margin
Total collapse in long-term shareholder value (-100% 5Y change)

Compare Another Pair

PRFX vs SPRC: Head-to-Head Comparison

This page compares PRF Technologies Ltd. (PRFX) and SciSparc Ltd. (SPRC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile